Breast Cancer

Showing NaN - NaN of 213

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Breast Cancer Trial in Worldwide (Dato-DXd, Durvalumab, Paclitaxel)

Not yet recruiting
  • Breast Cancer
  • Duarte, California
  • +111 more
Oct 23, 2023

Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Trial in Worldwide (Samuraciclib, Elacestrant DiHCl)

Recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Orange City, Florida
  • +27 more
Jul 19, 2023

Breast Cancer, Exercise Oncology, Cancer Survivors Trial in Madrid (Oncological physical exercise intervention, Active Physical

Active, not recruiting
  • Breast Cancer
  • +3 more
  • Oncological physical exercise intervention
  • Active Physical Activities intervention
  • Madrid, Spain
    Tigers Running Club
May 22, 2023

CELBREA® in Symptomatic Women or With Diagnostic Doubt of Breast

Enrolling by invitation
  • Breast Disease
  • +2 more
  • Celbrea
  • Madrid, Spain
    Hospital Universitario La Paz
May 10, 2023

Breast Cancer, Colon Cancer Trial in Madrid (Education program on healthy habits, Habitual)

Not yet recruiting
  • Breast Cancer
  • Colon Cancer
  • Education program on healthy habits
  • Habitual
  • Madrid, Spain
    Hospital Universitario Infanta Leonor
Apr 3, 2023

Cancer, Tumor, Solid, Advanced Solid Tumor Trial in Brussels, Barcelona, Madrid (JK08)

Recruiting
  • Cancer
  • +6 more
  • Brussels, Belgium
  • +3 more
Jan 30, 2023

Breast Cancer Trial in Worldwide (GDC-9545, Palbociclib, LHRH Agonist)

Active, not recruiting
  • Breast Cancer
  • Aurora, Colorado
  • +23 more
Jan 30, 2023

Breast Cancer Trial in Worldwide (Dato-DXd, Paclitaxel, Nab-paclitaxel)

Recruiting
  • Breast Cancer
  • Duarte, California
  • +260 more
Jan 19, 2023

Breast Cancer Trial in Spain (Olaparib)

Terminated
  • Breast Cancer
  • Barcelona, Spain
  • +7 more
Jan 18, 2023

Breast Cancer, Breast Cancer Metastatic Trial in Spain (Niraparib 100 MG, Aromatase Inhibitors)

Terminated
  • Breast Cancer
  • Breast Cancer Metastatic
  • Niraparib 100 MG
  • Aromatase Inhibitors
  • A Coruña, Spain
  • +9 more
Jan 17, 2023

Breast Cancer Trial in Worldwide (Perjeta, Herceptin, Docetaxel)

Active, not recruiting
  • Breast Cancer
  • Bruxelles, Belgium
  • +55 more
Jan 18, 2023

Breast Cancer Trial in Worldwide (Dato-DXd, Durvalumab, Capecitabine)

Recruiting
  • Breast Cancer
  • Gilbert, Arizona
  • +165 more
Jan 17, 2023

Breast Tumors, Breast Cancer, HER2-positive Early Breast Cancer Trial in Worldwide (Trastuzumab Deruxtecan, Paclitaxel,

Recruiting
  • Breast Neoplasms
  • +2 more
  • Trastuzumab Deruxtecan
  • +5 more
  • Springdale, Arkansas
  • +203 more
Jan 13, 2023

Breast Cancer Trial in Worldwide (Atezolizumab, Trastuzumab Emtansine, Placebo)

Recruiting
  • Breast Cancer
  • Alabaster, Alabama
  • +305 more
Jan 10, 2023

Breast Cancer Trial in Worldwide (Inavolisib, Placebo, Palbociclib)

Recruiting
  • Breast Cancer
  • Tucson, Arizona
  • +228 more
Jan 10, 2023

Breast Cancer Trial in Worldwide (trastuzumab, trastuzumab emtansine)

Active, not recruiting
  • Breast Cancer
  • Anchorage, Alaska
  • +275 more
Dec 13, 2022

Breast Cancer, Non-small Cell Lung Carcinoma Trial in Worldwide (Trastuzumab deruxtecan (DS-8201a), Pembrolizumab)

Recruiting
  • Breast Cancer
  • Non-small Cell Lung Carcinoma
  • San Francisco, California
  • +24 more
Nov 30, 2022

Breast Cancer Trial in Worldwide (Dato-DXd, Capecitabine, Gemcitabine)

Active, not recruiting
  • Breast Cancer
  • Duarte, California
  • +172 more
Dec 1, 2022

Breast Cancer Trial in Worldwide (Olaparib, Placebo)

Active, not recruiting
  • Breast Cancer
  • Anchorage, Alabama
  • +698 more
Nov 25, 2022

Follow-up in Early and Locally Advanced Breast Cancer Patients

Active, not recruiting
  • Breast Cancer
    • Aalst, Belgium
    • +27 more
    Nov 16, 2022

    Breast Cancer Trial in Worldwide (Alpelisib, Fulvestrant, Letrozole)

    Active, not recruiting
    • Breast Cancer
    • Gilbert, Arizona
    • +93 more
    Nov 10, 2022

    TNBC - Triple-Negative Breast Cancer, Breast Cancer Trial in Worldwide (Trilaciclib, Placebo, Gemcitabine)

    Active, not recruiting
    • TNBC - Triple-Negative Breast Cancer
    • Breast Cancer
    • Birmingham, Alabama
    • +111 more
    Oct 25, 2022

    Breast Cancer Trial in Worldwide (DS-8201a)

    Active, not recruiting
    • Breast Cancer
    • Anchorage, Alaska
    • +98 more
    Oct 17, 2022

    Breast Cancer Trial in Barcelona, Madrid, Valencia (Talimogene laherparepvec, Atezolizumab)

    Active, not recruiting
    • Breast Cancer
    • Barcelona, Spain
    • +3 more
    Sep 27, 2022